Arcus Biosciences 株価情報 (NYSE: RCUS)

最新ニュース Arcus Biosciences (NYSE:RCUS) 株価情報

ARCUS BIOSCIENCES INC

Arcus Biosciences

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Analyst Ratings

RCUS

アルカス・バイオサイエンス（Arcus Biosciences）（NYSE:RCUS）の株価予測がまたしても分析され、多くのアナリストの間でさまざまな意見が出された。

アルカス・バイオサイエンス　株価予測を公表

Arcus Biosciences Inc

On Tuesday, the Donald Trump administration announced that Treasury Secretary Scott Bessent and U.S. Trade Representative Jamieson Greer will <a href="https://www.benzinga.com/25/05/45160145/china-says-door-is-open-for-talks-while-it-is-assessing-us-trade-proposal-but-warns-coercion-and-extortion-wont-work">meet with senior Chinese</a> officials this weekend in Geneva, Switzerland.&nbsp;
What Happened: The gathering marks the first major face-to-face discussions between the two countries since the trade conflict began, <a href="https://apnews.com/article/trump-china-trade-switzerland-bessent-2a3335ed92989dc4b3a74ea550b79b3f?user_email=97d05b29432d778bbb1ffb8f16f2769451bf1d6125981f71ceccbe18ec8d01d8&amp;utm_medium=APNews_Alerts&amp;utm_source=Sailthru_AP&amp;utm_campaign=NewsAlert_May06_2025_06:55PM&amp;utm_term=AP%20News%20Alerts">reported</a> the Associated Press.
The Chinese Commerce Ministry confirmed that Vice Premier He Lifeng will represent Beijing during the talks.
The meetings are set to take place amid a backdrop of mounting tariffs, with the U.S. imposing duties of up to 145% on Chinese imports and China retaliating with tariffs of 125% on American goods.
In addition to their Chinese counterparts, Bessent and Greer are also scheduled to meet with Swiss President Karin Keller-Sutter, according to their offices, the report noted.
See Also: <a href="https://www.benzinga.com/media/25/05/45216185/bill-gates-says-trumps-climate-rollbacks-may-have-slowed-progress-but-microsoft-co-founder-doesnt-think-thats-a-permanent-thing-as-americas-commitment-to-clean-energy">Bill Gates Says Trump&#8217;s Climate Rollbacks May Have Slowed Progress, But Microsoft Co-Founder Doesn&#8217;t Think &#8216;That&#8217;s a Permanent Thing&#8217;</a>
Why It&#8217;s Important: In a note published Monday, veteran Wall Street investor Ed Yardeni said he's <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45192936/wall-street-veteran-investor-lowers-recession-risk-as-us-china-trade-war-cools">lowering his estimated probability</a> of a U.S. recession to 35%, down from 45% at the end of March.
The revised outlook, which returns to early March levels, signals increased optimism that tensions over tariffs between the U.S. and China may ease.
Last month, Morgan Stanley economists forecasted that the U.S. and China would initiate negotiations and steadily <a href="https://www.benzinga.com/markets/25/04/45065482/us-china-to-ease-tariffs-gradually-after-complex-talks-says-morgan-stanley-but-cuts-chinas-growth-outlook">reduce tariffs on Chinese imports</a> to 60% by the end of the second quarter. However, they do not anticipate a return to pre-Jan. 25 tariff levels.
The Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) has fallen 5.65% year-to-date, while the SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) is down 4.42%, as uncertainty over the U.S.-China trade war weighs on investor sentiment.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/04/45090992/mark-zuckerberg-warns-of-serious-disadvantage-as-chinas-data-center-blitz-could-let-deepseek-leapfrog-us-ai-labs" target="_blank" rel="noreferrer noopener">Mark Zuckerberg Warns Of ‘Serious Disadvantage&#8217; As China&#8217;s Data-Center Blitz Could Let DeepSeek Leapfrog US AI Labs</a></li>
</ul>
Photo Courtesy: Tomas Ragina on Shutterstock.com
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Government

News

Economics

Media

Scott Bessent To Meet Chinese Officials For Crucial Trade Talks In Switzerland: Trump Administration

Seattle-based startup EdgeRunner AI has announced the completion of a $12 million Series A funding round, aimed at advancing its development of offline <a href="https://www.benzinga.com/news/25/04/45047467/goodfire-lands-50m-from-anthropic-silicon-valley-giants-to-open-the-black-box-of-ai-before-it-rewrites-us-first">AI</a> agents tailored for military applications.
The company<a href="https://www.edgerunnerai.com/news/edgerunner-raises-17-5m-to-develop-air-gapped-on-device-ai-for-the-warfighter"> announced</a> last week that the funding round was led by Madrona, with participation from HP Tech Ventures, Four Rivers Ventures, and Alumni Ventures. This investment brings the company&#8217;s total funding to $17.5 million.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">How EdgeRunner Is Empowering Soldiers With On-Device Intelligence</h2>
EdgeRunner AI specializes in creating domain-specific AI agents that operate entirely on-device, eliminating the need for internet connectivity. These agents are designed to assist <a href="https://www.benzinga.com/25/02/44001823/china-us-to-begin-military-talks-signaling-possible-de-escalation-beijing-urges-america-first-in-nuclear-disarmament">military</a> personnel in decision-making processes, particularly in roles such as logistics and maintenance. By running AI models locally, the technology ensures low latency, reduced cloud costs, and enhanced data privacy, according to<a href="https://www.geekwire.com/2025/seattle-startup-edgerunner-ai-raises-12m-to-help-military-use-ai-without-the-internet/"> GeekWire</a>.
&#8220;We&#8217;re building the J.A.R.V.I.S. to your Ironman, but we&#8217;re starting with the warfighters first, because they need it,&#8221; co-founder and CEO Tyler Xuan Saltsman told GeekWire. Saltsman brings eight years of experience as an Army officer and logistician, along with roles at Amazon Web Services and Stability AI. Co-founder and Chief Operating Officer Colton Malkerson has a background in enterprise sales at Stability AI and experience within the U.S. government.
According to the company&#8217;s statement, the startup has entered into a Cooperative Research and Development Agreement with the U.S. Air Force Research Laboratory to develop AI agents customized for the&nbsp; Air Force&#8217;s unique occupational specialties. Additionally, EdgeRunner AI has been designated as an &#8220;awardable&#8221; vendor for the Department of Defense&#8217;s Tradewinds Solutions Marketplace, making its platform available to support critical missions across the Pentagon.&nbsp;
Trending: Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.
<h2 class="wp-block-heading">Strategic Backing and Industry Recognition Fuel EdgeRunner AI's Climb in Defense Tech</h2>
EdgeRunner AI's momentum is backed by a powerful roster of investors, a coalition of respected firms that brings not only capital but also strategic expertise in scaling breakthrough technologies.
Matt McIlwain, managing director at Madrona, has taken a board seat at EdgeRunner, GeekWire said. In a Madrona <a href="https://www.madrona.com/edgerunner-ai-air-gapped-on-device-agents/">statement</a> last week, McIlwain emphasized the precision of EdgeRunner's approach, calling it "domain-specific, highly intentional, and built to deliver value under the most difficult conditions."&nbsp;
EdgeRunner AI has also been recognized by<a href="https://www.cbinsights.com/research/report/artificial-intelligence-top-startups-2025/"> CB Insights</a>, being named to its AI 100 list, which highlights the most promising private AI companies globally. The company <a href="https://www.edgerunnerai.com/news/edgerunner-ai-featured-at-intel-vision-2025">said</a> it has showcased its technology at Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>)'s Vision event, highlighting its advancements in on-device AI for defense. According to a<a href="https://www.linkedin.com/posts/edgerunner-ai_nvidia-aisummit-edgeai-activity-7249776420149735424-NjU_"> LinkedIn</a> post, it also participated in the Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) AI Summit in October, further signaling its rising influence in the military technology landscape.
See Also: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a>
<h2 class="wp-block-heading">EdgeRunner AI Eyes Expansion as Demand Grows for Secure Tech Solutions</h2>
With the new funding, EdgeRunner AI plans to expand its team and invest further in product development. The company said in its statement last week that it aims to enhance its platform&#8217;s capabilities, ensuring that military personnel have access to reliable AI tools, even in environments with limited or no internet connectivity.
EdgeRunner is actively hiring across engineering, operations, and customer experience roles in preparation for its next phase of development, according to its <a href="https://www.edgerunnerai.com/careers/">website</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

INTC

NVDA

EdgeRunner AI Raises $12M Series A With Support From HP, Madrona, And Alumni Ventures To Advance Air-Gapped AI For Defense

India has launched missile strikes into Pakistani-controlled territory. The strikes resulted in at least eight deaths, as confirmed by Pakistani security officials on Tuesday.
What Happened: India fired missiles into Pakistani-controlled territory, causing multiple casualties. The Indian government claimed that the strikes were aimed at militant infrastructure, <a href="https://apnews.com/live/india-pakistan-attack-pahalgam-kashmir">reported</a> AP News.
The missile strikes come in the wake of a deadly attack on tourists in the disputed Kashmir region last month, which led to a severe strain in India-Pakistan relations. India has accused Pakistan of supporting the massacre, which resulted in the death of 26 men, mostly Indian Hindus — an accusation Pakistan vehemently denies.
Pakistan&#8217;s military spokesperson confirmed that six locations were hit by the missile strikes, resulting in eight deaths and 38 injuries. The Indian Defense Ministry, on the other hand, stated that&nbsp;at least nine sites were&nbsp;targeted, all of which were allegedly planning terrorist attacks against India.
In retaliation to the strikes, Pakistan&#8217;s Prime Minister&nbsp;Shehbaz Sharif&nbsp;stated, &#8220;Pakistan&nbsp;has every right to give&nbsp;a robust response to this&nbsp;act of war imposed by&nbsp;India, and a strong response&nbsp;is indeed being given.&#8221; The Indian army reported&nbsp;that Pakistan fired artillery along&nbsp;the de facto border in&nbsp;Bhimber Gali in India-controlled Kashmir.
The U.S. secretary of state, Marco Rubio, expressed his hope for a swift end to the conflict and pledged to continue engaging with both Indian and Pakistani leadership towards a peaceful resolution.
President Donald Trump said on Tuesday that the conflict "ends very quickly" and labeled it "a shame."
Photo Courtesy: xbrchx on Shutterstock.com
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Politics

General

India Fires Missiles Into Pakistani Territory, Trump Hopes Fighting Between Nuclear Rivals 'Ends Very Quickly'

Some people surprise their spouses with flowers. Others go big with vacations or jewelry.
But when you're Mark Zuckerberg, you think bigger. Like, 7 feet tall and made of turquoise and silver bigger.
The Meta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) CEO famously <a href="https://www.benzinga.com/general/entertainment/24/08/40411578/meta-ceo-mark-zuckerberg-commissions-statue-of-wife-priscilla-chan-sparks-online-buzz-bring">commissioned a towering sculpture of his wife</a>, Priscilla Chan, last August. At the time, the internet did what it does best—<a href="https://www.instagram.com/p/C-naZ9NvQNu/?igsh=MXZrcm9lZHVlNWhqNQ==">memed it into oblivion</a>. Avatar comparisons, jokes about what he must've done wrong, and memes telling women to "get a man who builds you a statue" filled social feeds.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
Now, almost a year later, Zuckerberg finally revealed what Priscilla actually thought of the gesture.
In an interview last week on the "<a href="https://youtu.be/zbfOkhrgxH0?si=rE5daEOfvVQ55Lul">This Past Weekend w/ Theo Von" podcast</a>, Zuckerberg admitted, "I don't think she was that happy with it." He added, "She doesn't want a sculpture of her in the front lawn—that's weird."
Still, he noted, "She's a good sport about it."
<h2 class="wp-block-heading">Not Exactly a "Magical Date"</h2>
When Theo Von asked if Zuckerberg had ever taken his wife on a "magical" dream date that <a href="https://www.benzinga.com/25/04/45093311/not-everyone-needs-a-thousand-ai-engineers-but-for-those-who-do-zuckerberg-says-meta-will-gladly-build-it-for-a-price">most people could only imagine</a>, the billionaire shrugged off the idea.
"She's pretty simple on this stuff," he explained. "I think most of the—you know, I like doing, I like making things."
And "making things" is exactly what led to the statue.
"I've always admired Daniel Arsham," Zuckerberg said, referring to the well-known pop sculptor. "We worked with him to make this sculpture of Priscilla because I thought it was cool."
Trending: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Why not a statue of himself? Zuckerberg was quick to shut that down.
"I'm not going to make a sculpture of myself. That's crazy, right? Like, who the [bleep] does that?"
So instead, Priscilla became the "target of my creative energy," he said.
<h2 class="wp-block-heading">‘This Is the Thing I Did Wrong'</h2>
The memes that followed the statue's unveiling didn't go unnoticed.
"There's all these memes online where people are like, ‘Wow, I wonder what Zuckerberg did wrong that he had to make a sculpture of his wife,'" he told Von. "And I'm like, no, you guys are totally missing this. This is the thing I did wrong."
Zuckerberg joked that if he ever did do something serious, people would have to wait and see what kind of over-the-top apology art he'd dream up next.
"She doesn't want a sculpture of her in the front lawn. It's like—that's weird," he repeated.
Still, he said Priscilla appreciated the effort. "I think she thinks it's sweet… There's a lot of more destructive things I could be doing with my creative energy."
See Also: <a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a>
<h2 class="wp-block-heading">His Creativity Doesn't Stop at Statues</h2>
The statue wasn't Zuckerberg's only grand gesture. He also mentioned he once designed a <a href="https://www.benzinga.com/personal-finance/25/04/45124694/mark-zuckerberg-says-his-wife-wanted-a-minivan-so-he-designed-a-porsche-hes-pretty-sure-should-exist-and-made-it-a-his-and-hers-set">custom Porsche minivan for Priscilla</a>.
"I like cars, but I'm not going to design a supercar for myself," he explained. "Let's design a sweet minivan for my wife."
According to Zuckerberg, "trying to be creative and show her some creativity" is his version of romance.
As for that massive sculpture? At least the DoorDash drivers know exactly where to leave the food.
"Just set it by the sculpture," Zuckerberg laughed.
Read Next:
<ul>
<li>Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

'That's Weird'—Mark Zuckerberg Gifted His Wife A 7-Foot-Tall Turquoise Statue Of Herself, But Says, 'I Don't Think She Was That Happy With It'

The agreement entered into is between WeightWatchers and holders of approximately 72% of the outstanding principal amount of the Company's term loan facility, revolving credit facility, and 4.5% senior secured notes, who have committed their support for the Transaction. To effectuate the Transaction, WeightWatchers has voluntarily initiated "pre-packaged" chapter 11 cases in the United States Bankruptcy Court for the District of Delaware (the "Court"). The Company expects to move through this process swiftly, with the goal of emerging from the court-supervised reorganization process in approximately 45 days, if not sooner.

Financing

WeightWatchers Files For 'Pre-Packaged' Chapter 11 Bankruptcy Aiming For Swift 45-Day Court-Supervised Reorganization

Granite Point Mortgage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPMT#NYSE">GPMT</a>) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0.73) by 21.92 percent. This is a 2000 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $8.04 million which missed the analyst consensus estimate of $8.86 million by 9.26 percent. This is a 35.80 percent decrease over sales of $12.52 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

GPMT

CORRECTION: Granite Point Mortgage Q1 Adj. EPS $(0.57) Beats $(0.73) Estimate, Sales $8.04M Miss $8.86M Estimate

loanDepot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDI#NYSE">LDI</a>) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.08) by 62.5 percent. This is a 8.33 percent decrease over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $273.62 million which missed the analyst consensus estimate of $274.97 million by 0.49 percent. This is a 22.82 percent increase over sales of $222.78 million the same period last year.

CORRECTION: loanDepot Q1 Adj. EPS $(0.13) Misses $(0.08) Estimate, Sales $273.62M Miss $274.97M Estimate

W&amp;T Offshore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 160 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $129.87 million which beat the analyst consensus estimate of $124.45 million by 4.35 percent. This is a 7.76 percent decrease over sales of $140.79 million the same period last year.

CORRECTION: W&T Offshore Q1 Adj. EPS $(0.13) Beats $(0.15) Estimate, Sales $129.87M Beat $124.45M Estimate

DGLY

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

Dynavax Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DVAX#NASDAQ">DVAX</a>) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $0.04 by 375 percent. This is a 57.14 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $68.16 million which missed the analyst consensus estimate of $70.58 million by 3.43 percent. This is a 34.21 percent increase over sales of $50.79 million the same period last year.

DVAX

CORRECTION: Dynavax Technologies Q1 Adj. EPS $(0.11) Misses $0.04 Estimate, Sales $68.16M Miss $70.58M Estimate

Brookdale Senior Living (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKD#NYSE">BKD</a>) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is unchanged from the same period last year. The company reported quarterly sales of $813.86 million which missed the analyst consensus estimate of $816.90 million by 0.37 percent. This is a 3.96 percent increase over sales of $782.83 million the same period last year.

UPDATE: Brookdale Senior Living Q1 Adj. EPS $(0.13) Misses $(0.11) Estimate, Sales $813.86M Miss $816.90M Estimate

Key Tronic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTCC#NASDAQ">KTCC</a>) reported quarterly losses of $(0.05) per share. This is a 76.19 percent increase over losses of $(0.21) per share from the same period last year. The company reported $111.97 million in sales this quarter. This is a 20.32 percent decrease over sales of $140.53 million the same period last year.

KTCC

CORRECTION: Key Tronic Q3 Adj. EPS $(0.05) Up From $(0.21) YoY, Sales $111.97M Down From $140.53M YoY

GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) has outperformed the market over the past 20 years by 1.01% on an annualized basis producing an average annual return of 9.2%. Currently, GEO Group has a market capitalization of $4.32 billion. 
Buying $100 In GEO: If an investor had bought $100 of GEO stock 20 years ago, it would be worth $512.81 today based on a price of $30.23 for GEO at the time of writing.
<h3>GEO Group's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746575121_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

Sanmina (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANM#NASDAQ">SANM</a>) has outperformed the market over the past 5 years by 9.29% on an annualized basis producing an average annual return of 23.11%. Currently, Sanmina has a market capitalization of $4.21 billion. 
Buying $1000 In SANM: If an investor had bought $1000 of SANM stock 5 years ago, it would be worth $2,735.49 today based on a price of $78.70 for SANM at the time of writing.
<h3>Sanmina's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746574226_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SANM

$1000 Invested In Sanmina 5 Years Ago Would Be Worth This Much Today

Before Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) became a $2 trillion tech giant, it was just an idea—and Jeff Bezos had something better than venture capital: his mom.
"I won the lottery with my mom. Thanks for literally everything," Bezos declared in a <a href="https://x.com/JeffBezos/status/863867801181855744?lang=en">heartfelt X post</a> on Mother's Day 2017.
Jacklyn Bezos had Jeff <a href="https://www.youtube.com/live/QJS-m-LyXMw?si=zVVDU7AUZZwb-INZ">when she was only 17</a>, defying the odds from day one. Pressured to drop out of high school, she stayed the course, graduated, and supported herself and her infant son on just $190 a month working as a secretary.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
At night, she attended school, showing up with two duffel bags—one packed with textbooks and the other with diapers, bottles, and toys to keep baby Jeff occupied.
After divorcing Jeff's biological father, Ted Jorgensen, she later married Miguel "Mike" Bezos, a Cuban immigrant who fled Castro's Cuba alone at age 16. Mike adopted Jeff and became the dad who raised him.
Jorgensen, a former circus unicyclist and bike shop owner, lost contact with Jeff shortly after the divorce. For decades, he didn't know what became of his son—until 2012, when a journalist tracked him down while researching Bezos' biography. "I wasn't a good father or a good husband," Jorgensen admitted at the time, expressing <a href="https://www.benzinga.com/news/24/12/42556247/jeff-bezos-biological-dad-didnt-know-he-was-a-billionaire-until-someone-said-your-son-is-one-of-the-most-successful-men-on-the-planet">regret that he never reconnected with Jeff</a> before his death in 2015.
Trending: Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.
In the early 1990s, Jeff Bezos was working on Wall Street when he became captivated by the rapid growth of internet usage. Recognizing the potential of e-commerce, he decided to leave his stable job and pursue his vision of an online bookstore. In 1994, he and his then-wife, <a href="https://www.benzinga.com/personal-finance/25/02/43916092/mackenzie-scott-gave-away-19-billion-of-her-38-billion-divorce-settlement-from-jeff-bezos-in-5-years-her-current-net-worth-may-shock-you">MacKenzie Scott</a>, drove across the country from New York to Seattle, drafting Amazon's business plan along the way.&nbsp;
That's when Jacklyn and Mike made a bold move. They didn't just give or loan him money. They invested $245,573—a significant piece of their life savings. Bezos later recalled in an <a href="https://achievement.org/achiever/jeffrey-p-bezos/">interview with the Academy of Achievement</a>, "The first initial start-up capital for Amazon.com came primarily from my parents, and they invested a large fraction of their life savings in what became Amazon.com."
Jeff even warned them upfront that there was a 70% chance they'd lose everything. Instead, their early equity stake—roughly 6% of the fledgling company—<a href="https://www.benzinga.com/startups/25/02/43666298/jeff-bezoss-mom-was-a-divorced-teen-who-couldnt-afford-a-phone-so-used-a-walkie-talkie-to-communicate-now-she-could-be-worth-76-billion">grew into billions</a>. Estimates from Bloomberg in 2018 placed the family's wealth from that <a href="https://www.bloomberg.com/news/articles/2018-07-31/a-hidden-amazon-fortune-bezos-parents-could-be-worth-billions">bet at around $30 billion</a>. Since the stock has grown significantly since 2018, their share could be worth more than double now, assuming they retained all original shares.&nbsp;
See Also: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a>
In 2022, Bezos posted <a href="https://x.com/JeffBezos/status/1523330938742005760?lang=en">another tribute on X, writing</a>: "Mom, I have no idea how you did what you did. You kept us both safe inside your heart. Thank you for sharing your strength and for all the sacrifices you made. I love you."
From night school duffel bags to one of the <a href="https://www.benzinga.com/personal-finance/25/01/42818961/jeff-bezos-urged-his-brother-and-sister-to-invest-10000-in-amazon-the-stake-grew-15499900-and-its-now-potentially-worth-1-5-billion">biggest fortunes in history</a>, Bezos' story is a reminder: sometimes, the best investors aren't venture capitalists. They're parents who believe—even when the odds say otherwise.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
</ul>
Image: Shutterstock

AMZN

Jeff Bezos Says He 'Won the Lottery' With His Teen Mom—She Had Him at 17, Took Him to Night School, Then Invested Her $245K Savings In Amazon

Imperial Oil (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IMO#AMEX">IMO</a>) has outperformed the market over the past 5 years by 21.66% on an annualized basis producing an average annual return of 35.49%. Currently, Imperial Oil has a market capitalization of $34.81 billion. 
Buying $1000 In IMO: If an investor had bought $1000 of IMO stock 5 years ago, it would be worth $4,481.65 today based on a price of $68.39 for IMO at the time of writing.
<h3>Imperial Oil's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746573314_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Lake Street analyst Thomas Flaten maintains Castle Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>) with a Buy and lowers the price target from $40 to $35.

Price Target

CSTL

Lake Street Maintains Buy on Castle Biosciences, Lowers Price Target to $35

Lake Street analyst Ryan Meyers downgrades TrueCar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUE#NASDAQ">TRUE</a>) from Buy to Hold and lowers the price target from $5 to $1.5.

Downgrades

TRUE

Lake Street Downgrades TrueCar to Hold, Lowers Price Target to $1.5

Loop Capital analyst Gary Mobley maintains ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Buy and lowers the price target from $65 to $55.

Loop Capital Maintains Buy on ON Semiconductor, Lowers Price Target to $55

Loop Capital analyst Gary Mobley maintains Lattice Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) with a Buy and lowers the price target from $85 to $75.

LSCC

Loop Capital Maintains Buy on Lattice Semiconductor, Lowers Price Target to $75

Press Releases

Arcus Biosciences Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor, and Announces Pricing of $150 Million Common Stock Offering

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2025 Financial Results and Pipeline Update

Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting

Arcus Biosciences Reports First-Quarter 2025 Financial Results and Provides a Pipeline Update

Ardelyx

Bicara Therapeutics

CareDx

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies

Dyne Therapeutics

89bio

Geron

GRAIL

Gyre Therapeutics

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

MiMedx Group

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics

Nurix Therapeutics

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Novavax

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Replimune Group

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

ARS Pharmaceuticals

Spyre Therapeutics

Vir Biotechnology

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics

Zymeworks

Barclays

HC Wainwright & Co.

B of A Securities

Morgan Stanley

Wells Fargo

アルカス・バイオサイエンス（Arcus Biosciences）（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCUS#NYSE">RCUS</a>）の株価予測がまたしても分析され、多くのアナリストの間でさまざまな意見が出された。
以下の表は最近のアナリスト評価を網羅し、過去30日間における意見の変遷を示している。
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th></th>
<th style="text-align: right;">買い評価</th>
<th style="text-align: right;">やや買い評価</th>
<th style="text-align: right;">無関心</th>
<th style="text-align: right;">やや売り評価</th>
<th style="text-align: right;">売り評価</th>
</tr>
</thead>
<tbody>
<tr>
<td>評価数</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>過去30日</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1ヵ月前</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2ヵ月前</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3ヵ月前</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
12か月間の株価ターゲットの評価では、アルカス・バイオサイエンスに対するアナリストの洞察が明らかとなり、平均ターゲット34.25ドル、最高評価44.00ドル、最低評価25.00ドルとなっている。現在のアナリストの平均評価は、37.75ドルという以前の平均株価ターゲット比9.27％低い。
<img decoding="async" src="https://www.benzinga.com/files/images/story/2024/1720472446_0.png" alt="price target chart" />
<h2>アナリスト評価の分析：詳細な内訳</h2>
金融専門家によるアルカス・バイオサイエンスの評価を、最近のアナリストの動向を通じて分析した。以下の要約は、主要なアナリスト、最近の評価、および評価と株価予測への調整を示している。
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th>アナリスト</th>
<th>アナリスト企業</th>
<th>アクション</th>
<th>評価</th>
<th>現在の株価ターゲット</th>
<th>以前の株価ターゲット</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Lawson</td>
<td>バークレイズ</td>
<td>引き下げ</td>
<td>オーバーウェイト</td>
<td>25.00ドル</td>
<td>35.00ドル</td>
</tr>
<tr>
<td>Asthika Goonewardene</td>
<td>トルイスト証券</td>
<td>引き下げ</td>
<td>Buy</td>
<td>44.00ドル</td>
<td>50.00ドル</td>
</tr>
<tr>
<td>Yigal Nochomovitz</td>
<td>シティグループ</td>
<td>引き上げ</td>
<td>Buy</td>
<td>38.00ドル</td>
<td>36.00ドル</td>
</tr>
<tr>
<td>Robert Driscoll</td>
<td>ウェダブ</td>
<td>維持</td>
<td>アウトパフォーム</td>
<td>30.00ドル</td>
<td>30.00ドル</td>
</tr>
</tbody>
</table>
<h3>主要な洞察：</h3>
<ul>
<li>アクション：市場の変動と企業の業績に反応し、アナリストたちは自らの推奨を更新している。アナリストたちがアルカス・バイオサイエンスに関連する最近の出来事に対する対応として‘維持&#8217;、‘引き上げ&#8217;、‘引き下げ&#8217;の立場を取ったかには、そのアナリストの会社に対する見解を示している。</li>
<li>評価：アナリストたちは、‘アウトパフォーム&#8217;から‘アンダーパフォーム&#8217;までの株式の質的評価を解き明かす。これらの評価は、アルカス・バイオサイエンスの総合的な市場への期待について洞察を提供している。</li>
<li>株価予測：アナリストたちは株価ターゲットの動向を評価し、アルカス・バイオサイエンスの株式の将来的な価値の見積もりを提供している。この比較は、アナリストたちの期待に関するトレンドを明らかにするものだ。</li>
</ul>
これらのアナリストの評価を金融指標と合わせて分析することで、アルカス・バイオサイエンスの市場での立ち位置を包括的に把握できるだろう。当社の評価テーブルのサポートを受け、情報を共有してくれ。
<a href="https://www.benzinga.com/quote/RCUS/analyst-ratings?utm_source=Benzinga Insights">アルカス・バイオサイエンスのアナリスト評価を最新の状況までご紹介。</a>
もし小型株のニュースと動きに関心があるならば、<a href="https://www.benzinga.com/news/small-cap">こちらからトラッキングを始める</a>
<h2>アルカス・バイオサイエンスの発見：より深く探る</h2>
アルカス・バイオサイエンスは臨床段階のバイオ製薬企業で、がんの治療用免疫療法の開発を行っている。同社は腫瘍微小環境内での免疫抑制の主要な原動力であるATP-アデノシン経路に焦点を当て、異なる小分子免疫腫瘍学製品候補を作成して最適化している。同社の製品パイプラインにはDomvanalimab、Etrumadenant、AB598、Casdatifanなどが含まれる。アルカスは肺がん、大腸がん、膵臓がんなどのさまざまながんについて臨床試験を実施している。同社は免疫療法の開発と商品化事業を行っている単一のセグメントを通じて事業を行っている。
<h3>アルカス・バイオサイエンスの財務パフォーマンス解説</h3>
時価総額：会社の時価総額は業界平均を上回る位置にあり、同社の市場での強力な存在感を示している。
収益のポジティブな動向：3か月間のアルカス・バイオサイエンスの財務状態を見ると、同社は好調な動向を示している。同社は2024年3月31日現在で480.0％という注目すべき収益成長率を達成し、売上高が大幅に増加した。同社は健康ケア部門での売上高の平均成長率よりも高い成長率を達成した。
純利益率：アルカス・バイオサイエンスの財務力は業界平均を上回っており、同社の強力な利益性と効率的な費用管理を示している。同社は-2.76％という目覚ましい純利益率を記録し、強力な利益率とコスト管理を達成している。
自己資本利益率（ROE）：アルカス・バイオサイエンスのROEは業界平均を上回っており、同社の効率的な株式資本利用と強力な財務パフォーマンスを示している。同社は-0.68％という印象的なROEを記録し、株式資本の効果的な利用と強力な財務パフォーマンスを実証している。
総資産利益率（ROA）：アルカス・バイオサイエンスのROAは業界基準を上回っており、同社の卓越した財務パフォーマンスを示している。80321同社のROAは-0.34％という印象的な数字を記録し、最適なリターンを得るために同社の資産を効果的に活用していることを裏付けている。
負債管理：アルカス・バイオサイエンスの負債比率は業界基準を下回っており、同社は0.02という健全な財務構造を持っていることを示している。
<h2>アナリスト評価はどのようにして決まるのか？</h2>
アナリスト評価は、銀行や金融機関の専門家が、各株式や定義済みセクターに関する結果を報告するもの（通常、各株式について四半期ごと）。
アナリストたちは、会社の業績発表、重要なインサイダーとの会話、会社の電話会議などから情報を集め、その結果を出すことが多い。アナリストの中には、成長予測、収益、売上などの指標に対する予測結果を公開して、評価についてのガイダンスを提供するアナリストもいる。
アナリスト評価を使用する際には、株式とセクターのアナリストも人間であり、投資家に意見を提供しているだけであるということを心に留めておくことが重要です。
アナリストの中でより良い結果を出しているアナリストを把握したい場合、最新のアナリスト評価をBenzinga Pro で評価スコア付きでチェックすることができます。
この記事はBenzingaの自動コンテンツエンジンによって生成され、Benzingaの編集者が確認しています。

Comments

Arcus Biosciences

ニュース

最新ニュース Arcus Biosciences (NYSE:RCUS) 株価情報

火曜日, 7 09, 2024

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル